MYELOBLASTIC LEUKEMIA TREATED WITH CHEMOTHERAPEUTIC DRUGS CLINICAL EVALUATION

dc.contributor.authorMONTERO UMANA, C
dc.contributor.authorCORDERO MURILLO, R
dc.contributor.authorBARRANTES
dc.date.accessioned2026-05-28T16:37:50Z
dc.date.issued1974
dc.description.paginacion508 - 513
dc.description.procedenciaLOC
dc.format.discursoArtículo
dc.format.extent6
dc.identifier.issn0025-7702
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/25167
dc.language.isoEspañol
dc.numero.secuencia25164
dc.publisherHOSP MEXICO,SECCION MED,SAN JOSE,COSTA RICA
dc.publisherHOSP MEXICO,LAB INVEST,SAN JOSE,COSTA RICA
dc.relation.ispartofseriesVol. 54 No. 1190
dc.source.revistafuenteREVISTA MEXICANA DE MEDICINA
dc.subjectMYELOBLASTIC, LEUKEMIA, TREATED, CHEMOTHERAPEUTIC, DRUGS, CLINICAL, EVALUATION
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaCIENCIAS CLINICAS
dc.subject.subdisciplinaPATOLOGIA CLINICA
dc.titleMYELOBLASTIC LEUKEMIA TREATED WITH CHEMOTHERAPEUTIC DRUGS CLINICAL EVALUATION
dc.title.alternativeREV MEX MED

Files